{"id":"https://openalex.org/W4416629771","doi":"https://doi.org/10.1158/1078-0432.30708669","title":"Supplementary Figure S2 from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial","display_name":"Supplementary Figure S2 from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial","publication_year":2025,"publication_date":"2025-11-25","ids":{"openalex":"https://openalex.org/W4416629771","doi":"https://doi.org/10.1158/1078-0432.30708669"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.30708669","doi":"https://doi.org/10.1158/1078-0432.30708669","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30708669","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.30708669","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090618504","display_name":"Heikki Joensuu","orcid":"https://orcid.org/0000-0003-0281-2507","observed_orcids":["https://orcid.org/0000-0003-0281-2507"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heikki Joensuu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0281-2507","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050792030","display_name":"Eva Wardelmann","orcid":"https://orcid.org/0000-0001-6788-4910","observed_orcids":["https://orcid.org/0000-0001-6788-4910"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eva Wardelmann","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6788-4910","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100774537","display_name":"Mikael Eriksson","orcid":"https://orcid.org/0000-0003-0463-0678","observed_orcids":["https://orcid.org/0000-0003-0463-0678"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mikael Eriksson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0463-0678","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020195438","display_name":"Annette Reichardt","orcid":"https://orcid.org/0009-0006-9451-4097","observed_orcids":["https://orcid.org/0009-0006-9451-4097"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annette Reichardt","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-9451-4097","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090145105","display_name":"Kirsten Sundby Hall","orcid":"https://orcid.org/0000-0002-2126-8255","observed_orcids":["https://orcid.org/0000-0002-2126-8255"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kirsten Sundby Hall","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2126-8255","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024711215","display_name":"Jochen Sch\u00fctte","orcid":"https://orcid.org/0009-0005-3692-0719","observed_orcids":["https://orcid.org/0009-0005-3692-0719"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jochen Sch\u00fctte","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-3692-0719","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078627364","display_name":"Silke Cameron","orcid":"https://orcid.org/0000-0003-2761-0960","observed_orcids":["https://orcid.org/0000-0003-2761-0960"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Silke Cameron","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2761-0960","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046601855","display_name":"Peter Hohenberger","orcid":"https://orcid.org/0000-0001-5359-5923","observed_orcids":["https://orcid.org/0000-0001-5359-5923"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Hohenberger","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5359-5923","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013518934","display_name":"Harri J. Sihto","orcid":"https://orcid.org/0000-0001-5265-5509","observed_orcids":["https://orcid.org/0000-0001-5265-5509"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harri Sihto","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5265-5509","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090397464","display_name":"Philipp Jakob Jost","orcid":"https://orcid.org/0000-0003-2454-0362","observed_orcids":["https://orcid.org/0000-0003-2454-0362"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philipp J. Jost","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2454-0362","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103179370","display_name":"Lars Hartwin Lindner","orcid":"https://orcid.org/0000-0003-3708-8264","observed_orcids":["https://orcid.org/0000-0003-3708-8264","https://orcid.org/0000-0002-0623-6976"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lars H. Lindner","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3708-8264","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031540987","display_name":"Sebastian Bauer","orcid":"https://orcid.org/0000-0001-5949-8120","observed_orcids":["https://orcid.org/0000-0001-5949-8120"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sebastian Bauer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5949-8120","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043335213","display_name":"Bengt Nilsson","orcid":"https://orcid.org/0009-0003-0919-0656","observed_orcids":["https://orcid.org/0009-0003-0919-0656"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bengt Nilsson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-0919-0656","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050914625","display_name":"Raija S. Kallio","orcid":"https://orcid.org/0000-0002-5912-496X","observed_orcids":["https://orcid.org/0000-0002-5912-496X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raija Kallio","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5912-496X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057335218","display_name":"Tommi Pesonen","orcid":"https://orcid.org/0009-0009-3513-8345","observed_orcids":["https://orcid.org/0009-0009-3513-8345"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tommi Pesonen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-3513-8345","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5048170384","display_name":"Peter Reichardt","orcid":"https://orcid.org/0009-0008-1410-3111","observed_orcids":["https://orcid.org/0009-0008-1410-3111"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Reichardt","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-1410-3111","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11485","display_name":"Gastrointestinal Tumor Research and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11485","display_name":"Gastrointestinal Tumor Research and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gastrointestinal-stromal-tumor","display_name":"gastrointestinal stromal tumor","score":0.9850000143051147},{"id":"https://openalex.org/keywords/kit-exon-11-mutation","display_name":"KIT exon 11 mutation","score":0.8360000252723694},{"id":"https://openalex.org/keywords/kit-exon-9-mutation","display_name":"KIT exon 9 mutation","score":0.9700000286102295},{"id":"https://openalex.org/keywords/pdgfra-mutation","display_name":"PDGFRA mutation","score":0.9850000143051147},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.9860000014305115},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.9909999966621399},{"id":"https://openalex.org/keywords/recurrence-free-survival","display_name":"recurrence-free survival","score":0.9929999709129333},{"id":"https://openalex.org/keywords/kaplan-meier-estimator","display_name":"Kaplan-Meier estimator","score":0.722000002861023},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.5820000171661377}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8429999947547913},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6822999715805054},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6509000062942505},{"id":"https://openalex.org/C36823959","wikidata":"https://www.wikidata.org/wiki/Q373027","display_name":"Exon","level":3,"score":0.5817999839782715},{"id":"https://openalex.org/C2777007597","wikidata":"https://www.wikidata.org/wiki/Q16869243","display_name":"Stromal tumor","level":3,"score":0.5720000267028809},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.5543000102043152},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.47530001401901245},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.461899995803833},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.41749998927116394},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.3982999920845032},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.37790000438690186},{"id":"https://openalex.org/C2775922572","wikidata":"https://www.wikidata.org/wiki/Q83567","display_name":"GiST","level":3,"score":0.34610000252723694},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.3249000012874603},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.29820001125335693},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.295199990272522},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.290800005197525},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2759000062942505},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.2727999985218048},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.27250000834465027},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.27000001072883606},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.26499998569488525},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.26159998774528503},{"id":"https://openalex.org/C2993683473","wikidata":"https://www.wikidata.org/wiki/Q30693176","display_name":"Amino acid substitution","level":4,"score":0.2606000006198883}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.30708669","doi":"https://doi.org/10.1158/1078-0432.30708669","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30708669","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30708669","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_S2_from_i_KIT_i_and_i_PDGFRA_i_Mutations_and_Survival_of_Gastrointestinal_Stromal_Tumor_Patients_Treated_with_Adjuvant_Imatinib_in_a_Randomized_Trial/30708669","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.30708669","doi":"https://doi.org/10.1158/1078-0432.30708669","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30708669","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362522227","https://openalex.org/W4366442094","https://openalex.org/W2600578302","https://openalex.org/W4385422936","https://openalex.org/W4386377436","https://openalex.org/W7131659643","https://openalex.org/W2794979659","https://openalex.org/W3045058880","https://openalex.org/W2395279578","https://openalex.org/W3200156849"],"abstract_inverted_index":{"Kaplan-Meier":[0],"estimates":[1],"of":[2,5],"recurrence-free":[3],"survival":[4,26],"patients":[6,15,31],"with":[7,16,34],"KIT":[8,17],"exon":[9,18],"11":[10],"substitution":[11],"mutation":[12,20],"(A)":[13],"and":[14,24],"9":[19],"(B).":[21],"The":[22],"5-year":[23],"10-year":[25],"rates":[27],"are":[28,32],"shown.":[29],"Censored":[30],"indicated":[33],"a":[35],"bar":[36]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2025-11-25T00:00:00"}